Currently predicting for Thu, 4 Jun 2026

ACLX Prediction Chart

ACLX Predictions History

Latest community submissions for ACLX.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 8, 2024 $97.26 -1.92% $103.06 X 94.37% 0
Nov 8, 2024 $97.97 -1.20% $103.06 X 95.06% 0
thedean2010 thedean2010 Merchant
Nov 8, 2024 Bullish $103.06 V 1
Sep 22, 2023 $33.88 -1.84% $33.96 V 99.75% 6
Sep 22, 2023 $34.11 -1.15% $33.96 V 99.55% 5
Sep 22, 2023 $35.40 +2.58% $33.96 X 95.76% 0
JS JS Pro
Sep 20, 2023 $36.38 +0.53% $34.51 X 94.58% 0
Sep 20, 2023 $35.57 -1.70% $34.51 V 96.92% 1
Sep 20, 2023 $35.81 -1.06% $34.51 V 96.25% 1
Sep 20, 2023 Bullish $34.51 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACLX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARCELLX, INC.
Arcellx
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent Sp...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE